## Abstract Platelet‐derived growth factor (PDGF) is a potent mitogenic and chemotactic cytokine, and PDGF‐C is a novel growth factor belonging to the PDGF family. In this study, to determine whether this growth factor can contribute to fibrosis and tissue remodeling, we examined the effect of PDGF
Differential regulation of transforming growth factor-β receptors type I and II by platelet-derived growth factor in human dermal fibroblasts
✍ Scribed by J. Czuwara-Ladykowska; E.A. Gore; D.A. Shegogue; E.A. Smith; M. Trojanowska
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 485 KB
- Volume
- 145
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We have previously found that transforming growth factor‐β1 (TGF‐β1) inhibits the mitogenic activity of platelet‐derived growth factor (PDGF) in cultures of human neonatal fibroblasts in a density‐dependent fashion. In the present investigation we determined the effect of TGF‐β1 on the
## Abstract Platelet‐derived growth factor (PDGF) and transforming growth factor β (TGF‐β), potent modulators of mesenchymal cell growth and differentiation, are often colocalizable in vivo. Previous in vitro studies in fibroblastic cell lines have shown variable, even antagonistic effects of TGF‐β
Activated liver fat-storing cells (FSC) are known to play a key role in the development of liver fibrosis. An important element in FSC activation process is the increased expression of receptors for platelet-derived growth factor (PDGF), a potent mitogen for FSC. The aim of the present study was to
Fibroblasts play a critical role in wound repair and in the development of fibrotic diseases, and transforming growth factor-beta (TGF-beta) has been shown to profoundly modulate fibroblast function. However, there is limited information on the TGF-beta receptor types, isoform specificity, and compl